Beneficiaries in 15-18 years age group to start getting second dose of COVID-19 vaccine from today
2 years, 10 months ago

Beneficiaries in 15-18 years age group to start getting second dose of COVID-19 vaccine from today

Firstpost  

Covaxin is the only vaccine option for the 15-18-year age group, according to health ministry guidelines on 27 December, 2021 New Delhi: Beneficiaries in the age group of 15 to 18 years will start receiving their second dose of COVID-19 vaccine from Monday, officials said. Delhi has around 10.14 lakh beneficiaries in the age group. Covaxin is the only vaccine option for the 15-to-18-year age group, according to Union Health Ministry guidelines on 27 December, 2021. Last week, Deputy Chief Minister Manish Sisodia had said 85 per cent of Delhi government school students have been vaccinated against COVID-19.

Delhi Age Group  vaccine  today  delhi  dose  start  ministry  health  guidelines  beneficiaries  drive  group  second  covid19  age  option  getting

History of this topic

Do kids still need the COVID-19 vaccine in Australia?
6 months, 3 weeks ago

Do kids still need the COVID-19 vaccine in Australia?

ABC  

If you're a parent wondering if you should have your child vaccinated against COVID-19, you might have jumped online to find out. The COVID-19 vaccine is not currently recommended for "healthy children", explains Daryl Cheng, an associate professor and immunisation consultant at Surveillance of Adverse Events Following Vaccination In the Community. For those children who have previously received COVID-19 immunisation, …

Over 30% Covaxin takers suffered from health issues after one year, claims BHU study
7 months, 1 week ago

Over 30% Covaxin takers suffered from health issues after one year, claims BHU study

New Indian Express  

NEW DELHI: Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow up study conducted by a team of researchers at Banaras Hindu University. Serious AESI, which included stroke and Guillain-Barre syndrome, were reported in one per cent of individuals, the study, which looked at …

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data
11 months, 3 weeks ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu  

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

Amid Covid surge, Tricity short of vaccine doses
1 year, 8 months ago

Amid Covid surge, Tricity short of vaccine doses

Hindustan Times  

Amid a surge in Covid infections, the Tricity is facing a glaring lack of vaccine availability. Director, health services, Dr Suman Singh has confirmed that the Covid-19 vaccine is currently unavailable, and the department has already communicated this to the Government of India for additional supplies. According to data provided by the health department, a total of 10,89,773 first doses …

Delhi records 300 fresh Covid cases in 24 hours, two deaths; positivity rate nearly 14 per cent
1 year, 8 months ago

Delhi records 300 fresh Covid cases in 24 hours, two deaths; positivity rate nearly 14 per cent

India TV News  

Covid alert: Delhi has reported 300 new Covid cases in the last 24 hours including 163 recoveries and two deaths. With 163 patients recovering in the last 24 hours, the total number of recoveries so far has gone to 19,82,029, while Delhi's total caseload is 20,09,361 and the death toll in the city has risen at 26,526. A total of …

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella
1 year, 10 months ago

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella

India TV News  

COVID-19 vaccine : Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday. "We dispatched three lakh doses of the world's first intranasal COVID-19 vaccine to some hospitals two days ago," Ella said. Establishing the UW-Madison Global One Health Centre holds great significance as …

Delhi to launch MR vaccination drive from Monday
1 year, 10 months ago

Delhi to launch MR vaccination drive from Monday

Hindustan Times  

The Delhi government is set to launch its campaign for the administration of the measles-rubella vaccine to children between the age of nine months and five years from Monday, the department of health and family welfare said on Friday, adding it aims to eliminate the diseases from the Capital by December this year. A senior official of the Delhi government’s …

Nasal vaccine at govt centres in Delhi from Feb 15
1 year, 10 months ago

Nasal vaccine at govt centres in Delhi from Feb 15

Hindustan Times  

India’s first nasal vaccine for Covid-19, iNCOVACC, which was formally launched on Thursday, is likely to be made available at government centres in the national capital by mid-February, senior officials of the Delhi government said on Friday. Union health minister Mansukh Mandaviya and science and technology minister Jitendra Singh launched Bharat Biotech’s nasal Covid vaccine, iNCOVACC, on the occasion of …

Not Permissible To Take One Dose Of Covishield And Another Of Covaxin: Centre To Delhi High Court
1 year, 10 months ago

Not Permissible To Take One Dose Of Covishield And Another Of Covaxin: Centre To Delhi High Court

Live Law  

The Central Government has informed the Delhi High Court that it is not permissible for an individual to take first dose of Covishield and second dose of Covaxin. Central Government’s standing counsel Anurag Ahluwalia told Justice Prathiba M Singh that mixing of two COVID-19 vaccines is not permissible for the first and second dose. The court was hearing a plea …

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
1 year, 10 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18  

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey
1 year, 11 months ago

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey

News 18  

At least 39% of respondents have already taken the Covid vaccine booster dose, while 6% plan to take the injectable booster and 4% the nasal one, a LocalCircles survey has found. Amid the uptick in Covid in cases in China and other countries, the Centre gave nod for Bharat Biotech’s intranasal COVID vaccine iNCOVAAC as a booster dose. Director General …

COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla
1 year, 11 months ago

COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla

Firstpost  

Pune: Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Poonawalla told the media that the vaccine works very well against the Omicron variant of coronavirus. Speaking to reporters on the sidelines of an event at the Bharati …

Second COVID-19 booster dose not required, says government sources
1 year, 11 months ago

Second COVID-19 booster dose not required, says government sources

Firstpost  

New Delhi: Based on the current Covid-19 situation in the country, there is no need to administer a second booster dose, government sources told ANI, as the Union Health Ministry data on Tuesday showed that only 134 new coronavirus cases were recorded throughout the nation in the last 24 hours with the daily positivity rate at 0.09 per cent “As …

No second Covid-19 booster dose required: Report
1 year, 11 months ago

No second Covid-19 booster dose required: Report

Live Mint  

There is no need to take a second booster dose against Covid-19 infection, news agency ANI reported on Tuesday citing government sources. According to the data by the Union Health Ministry, a total of 220.11 crore vaccine doses have been administered in the country, of which 95.13 crore have taken the second dose while only 22.41 crore of the population …

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
1 year, 11 months ago

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses

India TV News  

As Covid cases are increasing in the country, now focus is back on vaccination drive. According to sources- two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together have about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. Corbevax and Covaxin stocks Biological E held 200 million doses of its …

Bharat Biotech’s intranasal covid vaccine priced at ₹325 for govt hospitals
1 year, 11 months ago

Bharat Biotech’s intranasal covid vaccine priced at ₹325 for govt hospitals

Live Mint  

NEW DELHI: Bharat Biotech’s intranasal covid-19 vaccine--iNCOVACC --will be available for ₹325 per dose at government hospitals, and for ₹800 in private settings, the pharma major said on Tuesday. According to the company, iNCOVACC is the world’s first intranasal vaccine for covid-19 to have received approval for a primary two-dose schedule, and as a heterologous booster dose. Clinical trials were …

Nasal vaccines to roll out in private hospitals soon
2 years ago

Nasal vaccines to roll out in private hospitals soon

Hindustan Times  

A new coronavirus vaccine used as a nasal spray will only be available at private health facilities and the Co-WIN platform was set to be tweaked on Friday to allow people to immediately begin booking shots, people aware of the matter said on Friday. On Thursday, India’s technical expert committee on immunization— National Technical Advisory Group on Immunisation —recommended the …

90L in city yet to get booster shot, but BMC has only 6K Covaxin doses
2 years ago

90L in city yet to get booster shot, but BMC has only 6K Covaxin doses

Hindustan Times  

Even as the country is bracing up for a possible surge in Covid-19 cases, the Brihanmumbai Municipal Corporation has only 6,000 Covaxin doses left while there have been no stocks of Covishield or Corbevax for the last few months. BMC’s executive health officer Dr Mangala Gomare said only 16% of the eligible population have received the booster dose and around …

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost  

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

COVID-19 hospitalizations are rising in infants under 6 months, CDC director says
2 years, 1 month ago

COVID-19 hospitalizations are rising in infants under 6 months, CDC director says

LA Times  

Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, said COVID-19 hospitalizations are rising among babies under 6 months old who are too young to be vaccinated. COVID-19 hospitalizations are rising among babies under 6 months old, and the Centers for Disease Control and Prevention is urging mothers to get vaccinated to reduce the risk of infection …

50 million doses of Covaxin set to expire early 2023 due to poor offtake
2 years, 1 month ago

50 million doses of Covaxin set to expire early 2023 due to poor offtake

The Hindu  

Nearly 50 million doses of Bharat Biotech’s COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said. Due to lack of product demand, production stoppage of Covaxin - a two dose jab, was initiated by Bharat Biotech earlier this year, though the vaccine maker …

COVID: 50 million Covaxin doses set to expire early 2023 due to poor off take
2 years, 1 month ago

COVID: 50 million Covaxin doses set to expire early 2023 due to poor off take

India TV News  

Highlights Covaxin lying with the firm are set to expire early next year There are no takers owing to poor demand, said company sources India reported 1,082 fresh COVID-19 cases on Saturday Covaxin news: Nearly 50 million doses of Bharat Biotech’s COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers …

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget
2 years, 2 months ago

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget

The Hindu  

The government’s COVID-19 vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering ₹4,237 crore, or nearly 85% of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry. Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre …

COVID-19: Delhi High Court Closes Plea Challenging Centre's Permission For Clinical Trials Of Covaxin Among 2-18 Yrs Old
2 years, 3 months ago

COVID-19: Delhi High Court Closes Plea Challenging Centre's Permission For Clinical Trials Of Covaxin Among 2-18 Yrs Old

Live Law  

The Delhi High Court has disposed of a plea filed during the second wave of COVID-19 against Centre's permission for conducting Phase II and III clinical trials of Covaxin in the age group of 2 to 18 years. A division bench comprising of Chief Justice Satish Chandra Sharma and Justice Subramonium Prasad took note of the Supreme Court's judgment in …

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically
2 years, 4 months ago

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically

News 18  

Individuals who have received Covid-19 vaccines abroad and wish to get their second dose or booster shot in India can now do so. The development comes following an August 18 report by the Times of India which highlighted the issues people who had been jabbed abroad faced when they tried to receive a second or third shot here because the …

COVID-19: Corbevax to be given as boosters at vaccination centres from today
2 years, 4 months ago

COVID-19: Corbevax to be given as boosters at vaccination centres from today

Live Mint  

Hyderabad based-Biological E Ltd 's recently approved heterologous Covid-19 vaccine Corbevax to be available as a booster dose on the COWIN App in both public and private vaccination centres from 12 August, the firm said on 11 August. The Union Health Ministry approved Corbevax as India's first heterologous COVID-19 booster shot for 18 years and above after the six months …

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday
2 years, 4 months ago

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday

News 18  

Biological E. Ltd on Thursday said it has delivered 10 crore doses of its Covid-19 vaccine, Corbevax to the Centre so far which is expected to be available as a booster dose on the Cowin App in public and private vaccination centers from Friday. Corbevax was also approved by the Union Health Ministry as a heterologous Covid-19 booster dose under …

Corbevax as Covid booster for adults from August 12. Check details
2 years, 4 months ago

Corbevax as Covid booster for adults from August 12. Check details

India Today  

In a boost to India’s fight against coronavirus, the government gave nod to Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Announcing the decision, Union Health minister Mansukh Mandaviya said, “Further Strengthening India's arsenal against Covid-19, Ministry of Health and Family Welfare approves Corbevax as precaution dose for those …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

Deccan Chronicle  

New Delhi: The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield …

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report
2 years, 4 months ago

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report

Live Mint  

The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, news agency PTI has reported on 10 August citing official sources. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

India Today  

The government has approved Biological E's Corbevax as a precautionary dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday. "Corbevax will be considered as a precautionary dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for …

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients
2 years, 4 months ago

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients

News 18  

The Centre has approved Biological E’s Corbevax as a Covid-19 precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Union Health Secretary Rajesh Bhushan said, “Corbevax will be available as precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

India TV News  

Highlights Biological E's Corbevax has been approved as a booster or precaution dose. Covid vaccination: Biological E's Corbevax has been approved as a booster or precaution dose for those above the age of 18, and those who are fully vaccinated with either Covishield or Covaxin. "Corbevax will be considered as a precaution dose after completion of six months or 26 …

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon
2 years, 4 months ago

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon

News 18  

The Union health ministry is expected to soon approve Biological E’s Corbevax as a precaution dose for people above 18 years who are double vaccinated with either Covishield or Covaxin, official sources said on Tuesday. “Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose …

COVID-19: Over 7.20 crore unutilized vaccine doses available with States, Union Territories says health ministry
2 years, 4 months ago

COVID-19: Over 7.20 crore unutilized vaccine doses available with States, Union Territories says health ministry

Firstpost  

The vaccination drive has been ramped up through the availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain New Delhi: The Ministry of Health and Family Welfare on Sunday informed that more than 7.20 crore balance and unutilized COVID-19 vaccine doses are still available …

Go For More Tests, Faster Vaccination: Worried by Uptick in Covid Graph, Centre's Advisory to 7 States
2 years, 4 months ago

Go For More Tests, Faster Vaccination: Worried by Uptick in Covid Graph, Centre's Advisory to 7 States

News 18  

Ramp up testing, promote Covid-appropriate behaviour and increase the pace of vaccination, the Centre has told Delhi and six states amid a spike in coronavirus cases, especially ahead of the festive season. The state must also closely monitor districts reporting higher cases, positivity rates and clusters to prevent further spread of infection and effective case management,” he stressed in the …

Covid19 vaccine: Centre reduces gap between 2nd and precaution dose to 6 months on NTAGI's advice
2 years, 4 months ago

Covid19 vaccine: Centre reduces gap between 2nd and precaution dose to 6 months on NTAGI's advice

India TV News  

Highlights As of August 1, a total of 9.07 crore Covid precaution doses of vaccines were administered Centre has reviewed the pace of vaccination and issued multiple advisories to the states and UTs "Har Ghar Dastak 2.0" aims at vaccinating all beneficiaries through door-to-door mobilization Covid vaccine news: Based on the recommendations made by the National Technical Advisory Group on …

Covid-19 update: India sees another rise with 19,893 cases in 24 hrs
2 years, 4 months ago

Covid-19 update: India sees another rise with 19,893 cases in 24 hrs

Live Mint  

India on 4 August reported another rise in Covid-19 cases with 19,893 new infections. This sharp rise comes after India reported 17,135 Covid-19 on 3 August after a drop in infection a day prior with 13,734 cases and 34 deaths. Under the Covid-19 nationwide vaccination program, a total of 38,20,676 doses were administered in the last 24 hours taking India's …

Adults may get different vaccine as booster shot instead of Covishield, Covaxin
2 years, 4 months ago

Adults may get different vaccine as booster shot instead of Covishield, Covaxin

Live Mint  

As the government has continued to emphasize Covid booster doses due to the rising number of cases, a panel has recommended a different vaccine for Indian adults. Government panel National Technical Advisory Group on Immunisation has recommended Biological E's Corbevax as a precaution dose for adults fully vaccinated with either Covishield or Covaxin. "Corbevax may be considered for a third/precaution …

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre
2 years, 5 months ago

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre

Firstpost  

Minister of State for Health Bharati Pravin Pawar said as on 19 July, 2022, a total of 200.34 crore COVID-19 vaccine doses have been administered to beneficiaries above 12 years of age in the country New Delhi: India has supplied 23.9 crore doses of coronavirus vaccine to 101 countries and UN entities in the form of grant, commercial export, or …

4 Cr Eligible Beneficiaries Havn't Taken Even Single Dose of Covid-19 Vaccine as on July 18: Govt
2 years, 5 months ago

4 Cr Eligible Beneficiaries Havn't Taken Even Single Dose of Covid-19 Vaccine as on July 18: Govt

News 18  

An estimated 4 crore eligible beneficiaries have not taken even a single dose of COVID-19 vaccine as on July 18, Minister of State for Health Bharati Pravin Pawar informed the Lok Sabha on Friday. A total of 1,78,38,52,566 vaccine doses have been administered free of cost in Government Covid Vaccination Centres till July 18, she said in a written reply. …

COVID-19 vaccine Moderna is provisionally approved for kids under 5. This is what we know
2 years, 5 months ago

COVID-19 vaccine Moderna is provisionally approved for kids under 5. This is what we know

ABC  

Australian children aged six months to five years old could soon be rolling up their sleeves for a COVID-19 jab. On Tuesday, Australia's national medical regulator, the Therapeutic Goods Administration, announced Moderna's COVID-19 vaccine could safely be given to young children in doses one-quarter the size of that approved for adults. "The study demonstrated that the immune response to the …

India crosses milestone of 200 crore vaccinations against COVID-19 in 18 months
2 years, 5 months ago

India crosses milestone of 200 crore vaccinations against COVID-19 in 18 months

The Hindu  

India’s cumulative COVID-19 vaccination drive surpassed the 200-crore milestone on Sunday and as per provisional reports till 1 p.m., a total of 2,00,00,15,631 doses have been administered across the country. It took the country almost nine months to reach the 100-crore mark and another nine months to touch the 200-crore vaccination mark since the start of the drive on January …

PM Modi hails India\'s 200 crore COVID vaccination feat
2 years, 5 months ago

PM Modi hails India\'s 200 crore COVID vaccination feat

Deccan Chronicle  

New Delhi: India crossed the milestone of administering 200 crore Covid-19 vaccine doses at around Sunday noon, almost one-and-a-half years after starting the drive in January 2021. The administration of 200 crore doses includes 101.9 crore doses as the first jab, while 92.6 crore doses as the second and 5.49 crore as precaution dose. As many as 71 per cent …

’Only 10% got Covid-19 booster dose’: CM Arvind Kejriwal’s appeal to Delhi
2 years, 5 months ago

’Only 10% got Covid-19 booster dose’: CM Arvind Kejriwal’s appeal to Delhi

Live Mint  

Delhi Chief Minister Arvind Kejriwal on Sunday appealed to the people to get their Covid-19 precaution doses while highlighting that only around 10% people have done it so far. A total of 1.81 crore have been given first dose and 1.53 crore have received both doses, the Delhi chief minister said while emphasising that Delhi has capacity to administer one …

India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership
2 years, 5 months ago

India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership

News 18  

India has crossed record 200 crore mark in Covid-19 vaccinations within 18 months of launching the inoculation exercise in January last year. #200CroreVaccinations https://t.co/FtobFYBprV— Dr Mansukh Mandaviya July 17, 2022 A seven-phase vaccination drive was followed on the principle of Prioritization for Vaccine Administration based on scientific advice and global best practices, government officials told News18. While some experts had …

Kejriwal urges Delhiites to get Covid precaution dose, says 'will set up vaccination in schools'
2 years, 5 months ago

Kejriwal urges Delhiites to get Covid precaution dose, says 'will set up vaccination in schools'

India TV News  

Highlights Delhi Chief Minister Arvind Kejriwal on Sunday urged Delhiites to get the precaution dose. Delhi Covid 19 news: Delhi Chief Minister Arvind Kejriwal on Sunday urged Delhiites to get the precaution dose against Covid 19 saying only around 10 per cent of people has done so far in the city. He also urged parents to get their children aged …

Milestone! India crosses 2 billion Covid-19 vaccination mark in 18 months
2 years, 5 months ago

Milestone! India crosses 2 billion Covid-19 vaccination mark in 18 months

India TV News  

Highlights Total COVID-19 vaccine doses administered in India cross 200-crore mark 98% of adult population has received at least one dose while 90% have been fully vaccinated 81% of those aged 12-14 years have taken the first dose while 56% are fully vaccinated Covid-19 vaccines in India: India achieved a major milestone in its vaccination programme against COVID-19 as the …

Discover Related